Shandong Xinhua Pharmaceutical (000756.SZ) subsidiary obtains drug registration certificate for Donepezil Hydrochloride Orally Disintegrating Tablets.
Shandong Xinhua Pharmaceutical (000756.SZ) announced that recently, its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinda Pharmaceutical") received the Drug Registration Certificate for Donepezil Hydrochloride Orally Disintegrating Tablets (hereinafter referred to as "this product") approved and issued by the National Medical Products Administration. This product is used for the treatment of symptoms of mild, moderate, or severe Alzheimer's disease.
Shandong Xinhua Pharmaceutical (000756.SZ) announced that recently, the company's wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinda Pharmaceutical") received the Drug Registration Certificate for Donepezil Hydrochloride Orally Disintegrating Tablets (hereinafter referred to as "this product") approved and issued by the National Medical Products Administration. This product is used for the treatment of symptoms of mild, moderate, or severe Alzheimer's disease.
Related Articles
Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.
Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.
Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.
Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.
Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.
Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.
RECOMMEND
